Rep. Jared Moskowitz Sells Off Shares of Cigna Group (NYSE:CI)

Posted by Dante Gardener on May 2nd, 2026

Representative Jared Moskowitz (Democratic-Florida) recently sold shares of Cigna Group (NYSE:CI). In a filing disclosed on April 30th, the Representative disclosed that they had sold between $1,001 and $15,000 in Cigna Group stock on March 23rd. The trade occurred in the Representative’s “MORGAN STANLEY ACTIVE ASSETS (5)” account.

Representative Jared Moskowitz also recently made the following trade(s):

Purchased $1,001 – $15,000 in shares of Palo Alto Networks (NASDAQ:PANW) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of Cencora (NYSE:COR) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of McDonald’s (NYSE:MCD) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of GE Aerospace (NYSE:GE) on 3/31/2026.
Sold $15,001 – $50,000 in shares of Qualcomm (NASDAQ:QCOM) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of American Express (NYSE:AXP) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of Chubb (NYSE:CB) on 3/31/2026.
Sold $1,001 – $15,000 in shares of Cummins (NYSE:CMI) on 3/31/2026.
Purchased $1,001 – $15,000 in shares of General Dynamics (NYSE:GD) on 3/31/2026.

Cigna Group Trading Down 2.6%

Shares of Cigna Group stock opened at $283.14 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.74. The firm has a fifty day moving average price of $274.34 and a 200 day moving average price of $276.94. Cigna Group has a 1 year low of $239.51 and a 1 year high of $350.00. The stock has a market cap of $74.62 billion, a PE ratio of 12.77, a price-to-earnings-growth ratio of 1.01 and a beta of 0.26.

Cigna Group (NYSE:CI – Get Free Report) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. During the same quarter last year, the company posted $6.74 earnings per share. The firm’s revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities research analysts predict that Cigna Group will post 30.35 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is 28.13%.

Analysts Set New Price Targets

Several research analysts recently issued reports on CI shares. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. UBS Group reissued a “buy” rating and set a $375.00 target price on shares of Cigna Group in a report on Monday, February 9th. Cantor Fitzgerald raised their target price on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a report on Friday. Piper Sandler reduced their target price on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Finally, Zacks Research raised shares of Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, Cigna Group presently has an average rating of “Moderate Buy” and an average price target of $336.20.

Read Our Latest Research Report on Cigna Group

Institutional Trading of Cigna Group

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Global Assets Advisory LLC acquired a new stake in shares of Cigna Group in the first quarter valued at about $115,000. Diversify Wealth Management LLC grew its position in shares of Cigna Group by 88.1% in the first quarter. Diversify Wealth Management LLC now owns 3,961 shares of the health services provider’s stock valued at $1,158,000 after purchasing an additional 1,855 shares during the period. Carnegie Investment Counsel grew its position in shares of Cigna Group by 6.3% in the first quarter. Carnegie Investment Counsel now owns 3,752 shares of the health services provider’s stock valued at $1,001,000 after purchasing an additional 223 shares during the period. Citizens Financial Group Inc. RI grew its position in shares of Cigna Group by 9.2% in the first quarter. Citizens Financial Group Inc. RI now owns 10,025 shares of the health services provider’s stock valued at $2,674,000 after purchasing an additional 845 shares during the period. Finally, Fifth Third Bancorp grew its position in shares of Cigna Group by 211.9% in the first quarter. Fifth Third Bancorp now owns 76,660 shares of the health services provider’s stock valued at $20,449,000 after purchasing an additional 52,078 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Key Headlines Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an “outperform” rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
Positive Sentiment: Wells Fargo nudged its target to $305 (equal‑weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
Neutral Sentiment: Analyst/think‑piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer‑term sentiment but are not immediate catalysts. Read More.
Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short‑term execution and transition risk. Read More.
Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.

Insider Activity

In other news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.60% of the stock is owned by company insiders.

About Representative Moskowitz

Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida’s 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida’s 23rd Congressional District. He declared candidacy for the 2026 election.

Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor’s degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz’s career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.

About Cigna Group

(Get Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.